Treatment With the Human Once-Weekly Glucagon-Like Peptide-1 Analog Taspoglutide in Combination With Metformin Improves Glycemic Control and Lowers Body Weight in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone: A double-blind placebo-controlled study
AUTOR(ES)
Nauck, Michael A.
FONTE
American Diabetes Association
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2699710Documentos Relacionados
- Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study
- The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study.
- Baclofen for maintenance treatment of opioid dependence: A randomized double-blind placebo-controlled clinical trial [ISRCTN32121581]
- Effectiveness of tamsulosin in prevention of post-operative urinary retention: a randomized double-blind placebo-controlled study
- Double-blind, crossover, placebo-controlled clinical trial with clobetasol propionate in desquamative gingivitis